Cancer

Staging of Skin (Cutaneous) Melanoma
Cancer 18 Nov 2014

Staging of Skin (Cutaneous) Melanoma

Melanoma staging is a system for classifying melanoma skin cancer according to its severity in terms of tumour size, lymph node spread and metastasis at…
Melanoma
Cancer 13 Nov 2014

Melanoma

Skin cancer types including melanoma, squamous cell carcinoma and basal cell carcinoma can be prevented by reducing sun exposure. Find out more...
Cancer hair loss: Dr Andrew Dean
Cancer 19 Aug 2014

Cancer hair loss: Dr Andrew Dean

Hair loss is a common side effect of chemotherapy to treat cancer. Chemo hair loss can be reduced with cold caps and remedied with hair…
Diet and nutrition during cancer: Dr Andrew Dean
Cancer 19 Aug 2014

Diet and nutrition during cancer: Dr Andrew Dean

Dr Andrew Dean talks about the importance of nutrition during cancer treatments, and its intricacies.
Chemotherapy and sex: Dr Andrew Dean
Cancer 27 Jul 2014

Chemotherapy and sex: Dr Andrew Dean

Dr Andrew Dean explains the importance of intimacy and the possibilty of sex during on-going cancer treatments.
ICON8: An international phase III randomised trial of dose-fractionated chemotherapy compared to standard three-weekly chemotherapy, following immediate primary surgery or as part of delayed primary surgery, for women with newly diagnosed epithelial ovarian, fallopian tube or primary peritoneal cancer
Cancer 04 Jul 2014

ICON8: An international phase III randomised trial of dose-fractionated chemotherapy compared to standard three-weekly chemotherapy, following immediate primary surgery or as part of delayed primary surgery, for women with newly diagnosed epithelial ovarian, fallopian tube or primary peritoneal cancer

Short title ICON8 (Australia New Zealand Gynaecological Oncology Group trial number ANZGOG14) Summary ICON8 is a randomised (1:1:1 ratio), three-arm, three stage Gynaecologic Cancer InterGroup (GCIG) phase III trial designed to evaluate the safety and efficacy of dose-dense, dose-fractionated carboplatin-paclitaxel chemotherapy in the first-line treatment of ovarian cancer. Official title…
Secondary Thyroid Cancer More Deadly than Primary Malignancy in Young Individuals
Cancer 10 Mar 2014

Secondary Thyroid Cancer More Deadly than Primary Malignancy in Young Individuals

A new analysis has found that adolescents and young adults who develop thyroid cancer as a secondary cancer have a significantly greater risk of dying…
Big data set to make a big difference in childhood cancer treatment
Cancer 01 Jan 2014

Big data set to make a big difference in childhood cancer treatment

UTS research crunching vast amounts of data on childhood cancer to better tailor treatment is one step closer to assisting clinicians as the collaboration with…
Double-pronged attack could treat common children’s cancer
Cancer 22 Nov 2013

Double-pronged attack could treat common children’s cancer

A dual-pronged strategy using two experimental cancer drugs together could successfully treat a childhood cancer by inhibiting tumour growth and blocking off the escape routes it uses to become resistant to treatment, finds a new study published in Clinical Cancer Research on November 1st. Scientists at The Institute of Cancer Research, London, found…